Results 41 to 50 of about 39,697 (260)

Case Report: rTMS for recurrent major depressive disorder and generalized anxiety disorder comorbid with atrial fibrillation

Frontiers in Psychiatry
This paper examines the utilization of repetitive transcranial magnetic stimulation (rTMS) to treat recurrent Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) in a patient comorbid with atrial fibrillation (AF), a type of common ...
Vipul Reddy, Nadia Frutkin, Nadia Frutkin, Abeer Singh, Abeer Singh, Manya Pappu, Manya Pappu, Khimaya Raval, Khimaya Raval, Mark Odron, Charles Vigilia, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, David Baron, Keerthy Sunder, Keerthy Sunder, Keerthy Sunder, Keerthy Sunder   +21 more
doaj   +1 more source

Hybrid Solar Cell/Triboelectric Nanogenerator Based on Stable Two‐Dimensional Covalent Organic Frameworks

Advanced Functional Materials, EarlyView.
This study highlights the integration of stable two‐dimensional covalent organic framework (COF) films as photoactive layers in hybrid nanoenergy devices. The results demonstrate their capacity to generate electricity under both sunny and rainy conditions, showcasing versatility and resilience.
Joab D. Guerrero, Susana Ramos‐Terrón, Salvador R. G. Balestra, José M. Malagón, David Aparicio, Lucia Velasco, Asterios Charisiadis, Dooshaye Moonshiram, Margarita Darder, Pilar Aranda, Bernd Wicklein, Gustavo de Miguel, Javier Pérez‐Carvajal, Eva M. García‐Frutos   +13 more
wiley   +1 more source

Ketamine enhanced ECT in refractory recurrent depression.

European Psychiatry
Introduction Recurrent Depressive Disorder is a chronic condition that significantly impacts the quality of life. Despite various treatment options, some patients face severe and treatment-resistant relapses.
B. Arribas-Simon, P. Martinez.Gimeno, M. Calvo-Valcarcel, C. Alario-Ruiz, O. Martin-Santiago   +4 more
doaj   +1 more source

Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder [PDF]

Biological Psychiatry, 2014
While antidepressant treatment response appears to be partially heritable, no consistent genetic associations have been identified. Large, rare copy number variants (CNVs) play a role in other neuropsychiatric diseases, so we assessed their association with treatment-resistant depression (TRD).We analyzed data from two genome-wide association studies ...
Colm, O'Dushlaine, Stephan, Ripke, Douglas M, Ruderfer, Steven P, Hamilton, Maurizio, Fava, Dan V, Iosifescu, Isaac S, Kohane, Susanne E, Churchill, Victor M, Castro, Caitlin C, Clements, Sarah R, Blumenthal, Shawn N, Murphy, Jordan W, Smoller, Roy H, Perlis   +13 more
openaire   +2 more sources

Thermally Pre‐Formed Reconfigurable Resistive Random‐Access Memory Crossbar Arrays: A Dual‐Mode Platform for Robust Physically Unclonable Functions and In‐Memory Computing

Advanced Functional Materials, EarlyView.
A reconfigurable RRAM platform utilizing thermally pre‐formed filaments (TPFs) is developed to realize robust hardware security. By exploiting the thermodynamic stochasticity of TPFs, exceptionally reliable physically unclonable functions (PUFs) are achieved.
Seongbin Kwon, Taewon Lee, Dohyeong Kim, Sungmin Hwang, Sungjoon Kim   +4 more
wiley   +1 more source

Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality

Frontiers in Psychiatry
IntroductionTreatment-Resistant Depression (TRD) remains a major challenge in the management of Major Depressive Disorder (MDD). Esketamine, the S-enantiomer of ketamine and a glutamatergic modulator, was approved by the FDA and EMA for TRD in 2019 ...
Miriam Olivola, Miriam Olivola, Filippo Mazzoni, Barbara Tarantino, Alessandro Guffanti, Matteo Marcatili, Monica Macellaro, Monica Macellaro, Monica Macellaro, Nicolaja Girone, Nicolaja Girone, Nicolaja Girone, Vassilis Martiadis, Fabiola Raffone, Tiziano Prodi, Tiziano Prodi, Natascia Brondino, Giovanni Martinotti, Massimo Clerici, Massimo Clerici, Roberta Anniverno, Bernardo Dell’Osso, Bernardo Dell’Osso, Bernardo Dell’Osso, Bernardo Dell’Osso, Bernardo Dell’Osso, Bernardo Dell’Osso   +26 more
doaj   +1 more source

Treatment-resistant depressive disorders: The when, how and what of augmentation therapy [PDF]

Australian & New Zealand Journal of Psychiatry, 2019
Darryl Bassett, Gordon Parker, Amber Hamilton, Grace Morris, Bernhard T Baune, Philip Boyce, Malcolm Hopwood, Roger Mulder, Richard Porter, Ajeet Singh, Tim Outhred, Zola Mannie, Pritha Das and Gin S ...
Darryl Bassett, Gordon Parker, Amber Hamilton, Grace Morris, Bernhard T Baune, Philip Boyce, Malcolm Hopwood, Roger Mulder, Richard Porter, Ajeet Singh, Tim Outhred, Zola Mannie, Pritha Das, Gin S Malhi   +13 more
openaire   +3 more sources

Neuromorphic Electronics for Intelligence Everywhere: Emerging Devices, Flexible Platforms, and Scalable System Architectures

Advanced Materials, EarlyView.
The perspective presents an integrated view of neuromorphic technologies, from device physics to real‐time applicability, while highlighting the necessity of full‐stack co‐optimization. By outlining practical hardware‐level strategies to exploit device behavior and mitigate non‐idealities, it shows pathways for building efficient, scalable, and ...
Kapil Bhardwaj, Roshni Satheesh Babu, Yuxin Xia, Eva Bestelink, Radu Sporea, Nikos Hastas, Ioannis Zeimpekis, Dimitra G. Georgiadou, Sayani Majumdar   +8 more
wiley   +1 more source

Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM1

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView., 2023
Abstract Dynamin 1 is a GTPase protein involved in synaptic vesicle fission, which facilitates the exocytosis of neurotransmitters necessary for normal signaling. Pathogenic variants in the DNM1 gene are associated with intractable epilepsy, often manifested as infantile spasms at onset, developmental delay, and a movement disorder, and are located in ...
Davide Mei, Elena Parrini, Claudia Bianchini, Maria Luisa Ricci, Renzo Guerrini   +4 more
wiley   +1 more source

Magic mushrooms and mood: exploring Psilocybin as a depression treatment

Journal of the Pakistan Medical Association
Dear Editor, In view of ongoing global research on mental health, especially Major Depressive Disorder, we would like to draw attention to a psychedelic substance, Psilocybin, which has been emerging as a viable treatment option for MDD. Psilocybin is
Maria Rasool, Taha Muhammad Hannan, Muhammad Imam   +2 more
doaj   +1 more source